DZ2887A1 - Azetidine derivatives, their preparation and the drugs containing them. - Google Patents

Azetidine derivatives, their preparation and the drugs containing them.

Info

Publication number: DZ2887A1
Authority: DZ; Algeria
Prior art keywords: preparation; drugs containing; azetidine derivatives; azetidine; derivatives
Prior art date: 1998-09-11

Application number

DZ990187A

Other languages

French (fr)

Inventor

Daniel Achard

Herve Bouchard

Jean Bouquerel

Marc Capet

Serge Grisoni

Jean-Luc Malleron

Serge Mignani

Augustin Hittinger

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-08

Publication date

2003-12-15

1999-09-08 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

2003-12-15 Application granted granted Critical

2003-12-15 Publication of DZ2887A1 publication Critical patent/DZ2887A1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Cardiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Psychology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Addiction (AREA)
Hematology (AREA)
Virology (AREA)
Otolaryngology (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)

DZ990187A 1998-09-11 1999-09-08 Azetidine derivatives, their preparation and the drugs containing them. DZ2887A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9811342A FR2783246B1 (en)	1998-09-11	1998-09-11	AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM

Publications (1)

Publication Number	Publication Date
DZ2887A1 true DZ2887A1 (en)	2003-12-15

Family

ID=9530327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990187A DZ2887A1 (en)	1998-09-11	1999-09-08	Azetidine derivatives, their preparation and the drugs containing them.

Country Status (26)

Country	Link
EP (1)	EP1112251B1 (en)
JP (1)	JP4767413B2 (en)
CN (1)	CN1149191C (en)
AR (1)	AR021483A1 (en)
AT (1)	ATE239703T1 (en)
AU (1)	AU772025B2 (en)
BR (1)	BR9913592A (en)
CA (1)	CA2342739C (en)
CO (1)	CO5150230A1 (en)
CZ (1)	CZ301446B6 (en)
DE (1)	DE69907698T2 (en)
DK (1)	DK1112251T3 (en)
DZ (1)	DZ2887A1 (en)
ES (1)	ES2197666T3 (en)
FR (1)	FR2783246B1 (en)
HU (1)	HUP0103341A3 (en)
MA (1)	MA26685A1 (en)
MY (1)	MY119150A (en)
PL (1)	PL198526B1 (en)
PT (1)	PT1112251E (en)
RU (1)	RU2230739C2 (en)
TN (1)	TNSN99168A1 (en)
TR (1)	TR200100693T2 (en)
TW (1)	TW530046B (en)
WO (1)	WO2000015609A1 (en)
ZA (1)	ZA200102003B (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2799124B1 (en) *	1999-10-01	2004-08-13	Sanofi Synthelabo	USE OF ANTAGONISTS OF CENTRAL CANNABINOID RECEPTORS FOR THE PREPARATION OF DRUGS
WO2002010135A1 (en) *	2000-08-01	2002-02-07	Ono Pharmaceutical Co., Ltd.	3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
FR2814678B1 (en) *	2000-10-04	2002-12-20	Aventis Pharma Sa	COMBINATION OF AN ANTAGONIST OF THE CB1 RECEPTOR AND SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF OBESITY
FR2829028B1 (en) *	2001-08-29	2004-12-17	Aventis Pharma Sa	COMBINATION OF AN ANTAGONIST OF THE CB1 RECEPTOR AND A PRODUCT THAT ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF DISEASE
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
FR2833842B1 (en) *	2001-12-21	2004-02-13	Aventis Pharma Sa	PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
WO2003075917A1 (en)	2002-03-08	2003-09-18	Signal Pharmaceuticals, Inc.	Combination therapy for treating, preventing or managing proliferative disorders and cancers
US6825209B2 (en)	2002-04-15	2004-11-30	Research Triangle Institute	Compounds having unique CB1 receptor binding selectivity and methods for their production and use
JP4202319B2 (en)	2002-07-29	2008-12-24	エフ．ホフマン−ラロシュアーゲー	New benzodioxole
US7129239B2 (en)	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en)	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
EP1583762B1 (en)	2003-01-02	2008-07-09	F. Hoffmann-La Roche Ag	Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists
KR100704097B1 (en)	2003-01-02	2007-04-06	에프. 호프만-라 로슈 아게	Novel cb 1 receptour inverse agonists
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en)	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en)	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
FR2854633B1 (en) *	2003-05-07	2005-06-24	Sanofi Synthelabo	PIPERIDINYL-AND PIPERAZINYL-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
RU2006100298A (en)	2003-06-11	2006-05-10	Мерк энд Ко., Инк. (US)	SUBSTITUTED 3-ALKYL-AND 3-ALKENYLASETIDINE DERIVATIVES
MXPA05013733A (en)	2003-06-20	2006-03-08	Hoffmann La Roche	2-aminobenzothiazoles as cb1 receptor inverse agonists.
JP4527729B2 (en)	2003-12-08	2010-08-18	エフ．ホフマン−ラロシュアーゲー	New thiazole derivatives
CN100572375C (en)	2004-01-28	2009-12-23	霍夫曼-拉罗奇有限公司	Spiro-benzene and dioxole and as the application of CB1 antagonist
JP2007536298A (en)	2004-05-10	2007-12-13	エフ．ホフマン−ラ　ロシュ　アーゲー	Pyrrole or imidazole amide for the treatment of obesity
MX2007004910A (en)	2004-10-27	2007-06-14	Hoffmann La Roche	New indole or benzimidazole derivatives.
ES2351348T3 (en)	2004-11-09	2011-02-03	F. Hoffmann-La Roche Ag	DERIVATIVES OF THE DIBENZOSUBERONA.
EP1868999B1 (en)	2005-04-06	2009-07-01	F. Hoffmann-Roche AG	Pyridine-3-carboxamide derivatives as cb1 inverse agonists
JP4943826B2 (en) *	2005-11-25	2012-05-30	田辺三菱製薬株式会社	Pharmaceutical composition
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
BRPI0715160A2 (en)	2006-08-08	2013-06-11	Sanofi Aventis	arylamimoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, drugs comprising these compounds, and their use
EA200900392A1 (en)	2006-09-07	2010-06-30	Никомед Гмбх	COMBINED TREATMENT OF DIABETES MELLITUS
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
WO2008149345A2 (en)	2007-06-04	2008-12-11	Ben-Gurion University Of The Negev Research And Development Authority	Tri-aryl compounds and compositions comprising the same
EP2025674A1 (en)	2007-08-15	2009-02-18	sanofi-aventis	Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
EP2310372B1 (en)	2008-07-09	2012-05-23	Sanofi	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
SG178880A1 (en)	2009-08-26	2012-04-27	Sanofi Sa	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
EP2582709B1 (en)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
EP2683700B1 (en)	2011-03-08	2015-02-18	Sanofi	Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
EP2683701B1 (en)	2011-03-08	2014-12-24	Sanofi	Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use
WO2012120051A1 (en)	2011-03-08	2012-09-13	Sanofi	Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683702B1 (en)	2011-03-08	2014-12-24	Sanofi	New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
WO2012120057A1 (en)	2011-03-08	2012-09-13	Sanofi	Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2766349B1 (en)	2011-03-08	2016-06-01	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120053A1 (en)	2011-03-08	2012-09-13	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (en)	2011-03-08	2012-09-13	Sanofi	Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
BR112013031493B1 (en) *	2011-06-10	2022-04-19	Chiesi Farmaceutici S.P.A	Compound, pharmaceutical composition, use of a compound, combination of a compound, device and process for preparing a compound
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP3065723B1 (en)	2013-11-05	2020-09-23	Ben Gurion University of the Negev Research and Development Authority	Compounds for the treatment of diabetes and disease complications arising from same
CN115124447A (en) *	2022-08-29	2022-09-30	山东诚创蓝海医药科技有限公司	Preparation method of 3-azetidinone hydrochloride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4133881A (en) *	1977-04-27	1979-01-09	A. H. Robins Company, Incorporated	Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) *	1979-07-19	1980-12-30	A. H. Robins Company, Inc.	Production of methylene-cycloamines
US4260606A (en) *	1979-07-19	1981-04-07	A. H. Robins Company, Inc.	3-Methyleneazetidine derivatives
US5151418A (en) *	1985-02-28	1992-09-29	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5183902A (en) *	1985-02-28	1993-02-02	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides

1998
- 1998-09-11 FR FR9811342A patent/FR2783246B1/en not_active Expired - Fee Related
1999
- 1999-09-01 TW TW088115056A patent/TW530046B/en not_active IP Right Cessation
- 1999-09-07 MY MYPI99003867A patent/MY119150A/en unknown
- 1999-09-08 DZ DZ990187A patent/DZ2887A1/en active
- 1999-09-08 TN TNTNSN99168A patent/TNSN99168A1/en unknown
- 1999-09-08 MA MA25758A patent/MA26685A1/en unknown
- 1999-09-09 CA CA002342739A patent/CA2342739C/en not_active Expired - Fee Related
- 1999-09-09 BR BR9913592-2A patent/BR9913592A/en not_active Application Discontinuation
- 1999-09-09 AT AT99941728T patent/ATE239703T1/en active
- 1999-09-09 RU RU2001110080/04A patent/RU2230739C2/en not_active IP Right Cessation
- 1999-09-09 HU HU0103341A patent/HUP0103341A3/en unknown
- 1999-09-09 CZ CZ20010883A patent/CZ301446B6/en not_active IP Right Cessation
- 1999-09-09 DK DK99941728T patent/DK1112251T3/en active
- 1999-09-09 TR TR2001/00693T patent/TR200100693T2/en unknown
- 1999-09-09 PT PT99941728T patent/PT1112251E/en unknown
- 1999-09-09 ES ES99941728T patent/ES2197666T3/en not_active Expired - Lifetime
- 1999-09-09 AU AU55232/99A patent/AU772025B2/en not_active Ceased
- 1999-09-09 DE DE69907698T patent/DE69907698T2/en not_active Expired - Lifetime
- 1999-09-09 EP EP99941728A patent/EP1112251B1/en not_active Expired - Lifetime
- 1999-09-09 JP JP2000570149A patent/JP4767413B2/en not_active Expired - Fee Related
- 1999-09-09 CN CNB99810762XA patent/CN1149191C/en not_active Expired - Fee Related
- 1999-09-09 WO PCT/FR1999/002147 patent/WO2000015609A1/en not_active Application Discontinuation
- 1999-09-09 PL PL346530A patent/PL198526B1/en not_active IP Right Cessation
- 1999-09-10 CO CO99057627A patent/CO5150230A1/en unknown
- 1999-09-10 AR ARP990104563A patent/AR021483A1/en active IP Right Grant
2001
- 2001-03-08 ZA ZA200102003A patent/ZA200102003B/en unknown

Also Published As

Publication number	Publication date
CZ2001883A3 (en)	2001-06-13
MA26685A1 (en)	2004-12-20
ZA200102003B (en)	2002-08-28
DE69907698D1 (en)	2003-06-12
TNSN99168A1 (en)	2005-11-10
HUP0103341A3 (en)	2002-10-28
AR021483A1 (en)	2002-07-24
CZ301446B6 (en)	2010-03-03
JP2002525267A (en)	2002-08-13
CN1316991A (en)	2001-10-10
CA2342739C (en)	2009-09-08
PL198526B1 (en)	2008-06-30
CO5150230A1 (en)	2002-04-29
HUP0103341A2 (en)	2002-02-28
ES2197666T3 (en)	2004-01-01
FR2783246B1 (en)	2000-11-17
JP4767413B2 (en)	2011-09-07
TR200100693T2 (en)	2001-07-23
AU5523299A (en)	2000-04-03
RU2230739C2 (en)	2004-06-20
BR9913592A (en)	2001-06-12
FR2783246A1 (en)	2000-03-17
EP1112251A1 (en)	2001-07-04
EP1112251B1 (en)	2003-05-07
CN1149191C (en)	2004-05-12
DE69907698T2 (en)	2004-03-25
MY119150A (en)	2005-04-30
PL346530A1 (en)	2002-02-11
ATE239703T1 (en)	2003-05-15
TW530046B (en)	2003-05-01
DK1112251T3 (en)	2003-09-01
PT1112251E (en)	2003-09-30
CA2342739A1 (en)	2000-03-23
WO2000015609A1 (en)	2000-03-23
AU772025B2 (en)	2004-04-08

Publication	Publication Date	Title
DZ2887A1 (en)	2003-12-15	Azetidine derivatives, their preparation and the drugs containing them.
FR2711993B1 (en)	1995-12-01	Drugs containing 7H-imidazol [1,2-a] pyrazine-8-one derivatives, new compounds and their preparation.
FR2700167B1 (en)	1995-02-03	Pyrrolidine and thiazolidine derivatives, their preparation and the drugs containing them.
FR2805818B1 (en)	2002-04-26	AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2708608B1 (en)	1995-10-27	N-sulfonylbenzimidazolone derivatives, their preparation, pharmaceutical compositions containing them.
DZ2009A1 (en)	2002-10-23	New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2708606B1 (en)	1995-10-27	N-phenylalkylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
DZ2149A1 (en)	2002-10-23	New taxoids, their preparation and the pharmaceutical compositions containing them.
DZ2890A1 (en)	2003-12-15	4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them.
DZ2461A1 (en)	2003-01-18	New arylkylamine derivatives and pharmaceutical composition containing them.
FR2696176B1 (en)	1994-11-10	Piperidine derivatives, their preparation and their therapeutic application.
FR2677984B1 (en)	1994-02-25	N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2732967B1 (en)	1997-07-04	1-PHENYLPYRAZOLE-3-CARBOXAMIDES SUBSTITUTED, ACTIVE IN NEUROTENSIN, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DZ2594A1 (en)	2003-02-22	Novel 2-aminopyridine derivatives and pharmaceutical compositions containing them.
MA26490A1 (en)	2004-12-20	NOVEL TETRAHYDROISOQUINOLEIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ITTO990784A0 (en)	1999-09-14	PROCEDURE FOR STRENGTHENING THE ANTI-CANCER ACTIVITY OF RAW DRUGS, COMPOSITION CONTAINING A RAW DRUG STRENGTHENING THE ACTIVITY
MA26552A1 (en)	2004-12-20	NOVEL ISOQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2687401B1 (en)	1994-05-20	1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2796380B3 (en)	2001-08-17	NOVEL AMINOTHIAZOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2705671B1 (en)	1995-07-07	New hydroxybiphenyl derivatives, their preparation and the pharmaceutical compositions containing them.
FR2703995B1 (en)	1995-07-21	5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9811582B1 (en)	2010-10-19	compounds derived from 4-oxo-3,5-dihydro-4h-pyridazine [4,5-b] indole-1-acetamide, medicament and pharmaceutical composition containing them.
FR2712288B1 (en)	1996-01-05	New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2717811B1 (en)	1996-04-26	Imidazo [1,2-a] pyrazine-4-one derivatives, their preparation and drugs containing them.
FR2712289B1 (en)	1996-01-05	New taxicin derivatives, their preparation and the pharmaceutical compositions containing them.